2137 - 2148 of 7601 results
0.25 CME CREDIT

COVID-19 Vaccine: Get the Facts and Bust the Myths

Guest: Alan Ehrlich, MDMusic Credit: Richard Onorato

0.25 CME


Clinical Considerations in Stroke or Transient Ischemic Attack

Industry Webcast Sponsored by AstraZeneca Pharmaceuticals LP; Not for CME/CE Credit


Clinical Considerations in Stroke or Transient Ischemic Attack

Industry Webcast Sponsored by AstraZeneca Pharmaceuticals, LP; Not for CME/CE Credit

• Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA). • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial


1 CME CREDIT

Review practice-changing articles from 2020! During this informative session on medical literature updates (excluding COVID-19), primary care physician, Dr. Charles Vega, will review the clinical implications of practice-changing literature that has been recently published. Topics for discussion will include: HPV vaccination, mammography, colorectal cancer screening, osteoporosis, coconut oil, milk and weight gain, mask efficacy, COPD exacerbations, medication-assisted treatment for opioid disorder and more! You don’t want to miss these important updates!


Group of Primary Care Doctors Smiling

PrimaryCareNOW: A Pri-Med Virtual Conference. Earn up to 6.50 CME/CE credits in one day during this virtual CME conference.


0.5 CME CREDIT

Jeopardy! GLP-1 RA Edition

0.50 CME
0.41 AANP | 0.41 Pharmacology

Think you know it all about GLP-1 receptor agonists? Test your familiarity with these dynamic diabetes drugs in Jeopardy game show. This interactive game will allow you to showcase your knowledge on GLP-1 RA pharmacodynamics, clinical indications, cardiovascular benefits, and more. There will be a rationale following each question, ensuring that you have answers to take back to your practice. Please note that any data, indications, and guidelines presented in this activity are current as of 08/14/20 and they are subject to change as new information is published.


healthcare provider counselling a person with obesity
0.25 CME CREDIT

Traversing the Chasm: Overcoming Challenges of Obesity Management in Primary Care: Module 2

An Adaptive Learning Experience

0.25 CME/MOC
0.25 AANP | 0.25 Pharmacology

Obesity is a growing epidemic in the United States, and effective treatment of this chronic disease requires evidence-based implementation of treatment approaches. This activity will discuss best practices for approaching the person with obesity and individualizing obesity treatment plans. It will include weight loss pharmacotherapy and approaches to address and overcome barriers to weight loss.


healthcare provider counselling a person with obesity
0.5 CME CREDIT

Traversing the Chasm: Overcoming Challenges of Obesity Management in Primary Care: Module 1

An Adaptive Learning Experience

0.50 CME/MOC
0.38 AANP | 0.19 Pharmacology

Obesity is a growing epidemic in the United States, and effective treatment of this chronic disease requires evidence-based implementation of treatment approaches. This activity will discuss best practices for approaching the person with obesity and individualizing obesity treatment plans. It will include weight loss pharmacotherapy and approaches to address and overcome barriers to weight loss.


Nurse explaining the use of diabetic equipment to a patient
0.5 CME CREDIT

Time to meet your new patient! In this interactive activity, you will be guided through the case of a patient with type 2 diabetes at high-risk for atherosclerotic cardiovascular disease (ASCVD) via a series of questions and complementary videos. Questions will test your strengths and weaknesses around diabetes management, with some questions and feedback tailored directly to your management choices. After each question, you will be presented with learning moments designed to help increase your confidence managing patients with type 2 diabetes and reducing cardiovascular risk.